Eden Research Share Discussion Threads

[supersonico] 28/4/2018 09:12

Eastman 1st quarter results.



Outlook

Commenting on the outlook for full-year 2018, Costa said: "Our compelling performance in the first quarter gives us increasing confidence in our growth expectations for the year. Our innovation-driven growth model continues to deliver results, driving impressive growth in our specialty businesses. In addition, the use of our strong free cash flow along with a modestly lower tax rate is contributing to earnings growth. We continue to work hard to offset volatility in raw material and energy prices, particularly olefins. Taking all of this together, we are increasing our expectations for adjusted 2018 EPS growth to be between 10-14 percent."

The full-year 2018 projected earnings exclude any non-core, unusual, or non-recurring items in the remaining nine months of 2018, and assumes that the adjusted tax rate detailed in Tables 4A and 4B for first quarter 2018 will be the actual rate for full-year 2018. Our 2018 financial results forecasts do not include non-core items (such as mark-to-market pension and other postretirement benefit gain or loss) or any unusual or non-recurring items, and we accordingly are unable to reconcile projected full-year 2018 earnings excluding non-core and any unusual or non-recurring items to projected GAAP earnings without unreasonable efforts.

[investingisatrickygame] 27/4/2018 11:54

Super,

I assume this to be a good opportunity for Eden and their professional help to capitalise on this announcement and further vocalise the developments of a British company in delivering natural solutions to compete against traditional pesticides, herbicides and insecticides.

Furthermore, this is probably, hopefully, just an initial step by the EU on a larger scale attack against harmful chemical products that would naturally lead companies to either/and 1) Escalate their R and D 2) Seek out alliances with companies who are further advanced in non-chemical deliverables 3) Buy companies that offer 2)

[northwick] 27/4/2018 09:38

Wonder when we will the get some news from the company. Sean Smith did say it will be imminent at the last Agm. But that was some 9 months ago.

[investingisatrickygame] 26/4/2018 17:21

Super,

I do

[supersonico] 26/4/2018 14:15

New Sipcam Corporate video;


...........

Investing..do you mean Sumiagro?

[investingisatrickygame] 26/4/2018 13:42

Surely Sipcam will be making representations to Nicholas Hulot ASAP, together with Eden

[supersonico] 26/4/2018 12:02

Pesticides: a new timid plan to reduce the dependence of French agriculture
For the NGO Générations futures, "the account is not there", especially on the glyphosate for which the government proposes only new studies.



No less than four ministers for a highly anticipated plan. Nicolas Hulot (ecology), Agnès Buzyn (health), Stéphane Travert (agriculture) and Frédérique Vidal (research) presented, Wednesday, April 25, the "action plan to reduce the dependence of agriculture on plant protection products." With an estimated consumption of more than 60 000 tonnes per year, French agriculture remains a champion of Europe pesticides and seems unable to get rid of it despite the proliferation of health warnings, including the most used herbicides, the famous glyphosate of Monsanto.
Read also: The decree governing the use of pesticides in France attacked before the Council of State
Ten years ago, in the wake of the Grenelle de l'environnement, the first government plan Ecophyto aimed a halving of the use of pesticides by 2018. Intense - consumption continues to increase - this objective has 2025 in the Ecophyto 2 plan, with an intermediate level of 25% in 2020. One of the four priorities of the series of actions unveiled on 25 April is to strengthen and improve the functioning of Ecophyto 2, including a version "2 +" must be presented in June.

In order to "rapidly reduce the use of substances of most concern for health and the environment", the ministers assure that "legislative and financial levers will be mobilized". They recall that the draft law from the Estates General of Food, under discussion in the National Assembly, provides for provisions relating to the separation of the sale and advice of phytopharmaceutical products.
This is an essential demand in the eyes of associations that denounce the pathologies related to environmental degradation. The government is also announcing that a "major investment plan" - the amount of which is not yet known - will be partly mobilized to support research and development and the dissemination of alternative methods to pesticides.
Nicolas Hulot hailed an "unprecedented action plan" and assured that "these measures will be implemented very quickly, and will enable us to reach our phytosanitary reduction objectives and to build alternatives, in particular to the use of glyphosate. ". On the NGO side, we are much less enthusiastic.

"Lack of breath and political will"
"The account is clearly not there. The whole lack of breath and political will, "said François Veillerette, the director of future generations. The association, which participated in the public consultation prior to the establishment of this plan, is at the origin of an appeal before the Council of State against the decree of May 4, 2017 framing the use of pesticides. It is pleased that "the situation of residents of cultivated areas seems to be taken into account by the Ministries of Environment and Health". The device proposes to define, by regulation, "untreated areas for the use of products classified as dangerous". But without defining its boundaries, says Mr. Veillerette.
Above all, the NGO does not hide its disappointment on glyphosate, classified "probable carcinogen" since 2015 by the International Agency for Research on Cancer. "The only response of the plan is to ask for collective expertise [on health risks] and to develop specifications for a new [carcinogenicity] experimental study whose results will come ... in 2020! "Laments the association. For its director, it's "unacceptable".
When, after two years of battles and controversies, the European Union reauthorized the herbicide for five years, at the end of 2017, Emmanuel Macron announced that France would ban it "at the latest in three years".
.................................................................

EU Member States Vote Neonicotinoids Ban April 27, 2018

[weyweyumfozo] 25/4/2018 19:42

FTSE 250 territory - I'll hold out for a bit more then!

[northwick] 25/4/2018 19:12

Long standing shareholders will not accept £1.00. They expect multiples of this. Advise who ever is making a list to use a pencil, and keep a rubber handy just in case the price needs amending.Long way to go yet.

[weyweyumfozo] 25/4/2018 18:04

If they want to make a list, they can put my shares on it at £1 each.

[investingisatrickygame] 25/4/2018 17:29

Super,

When Eden announces (hopefully) that its encapsulation technology is being used as the release mechanism for ANO's active ingredients, there should be absolute fireworks under the share price. Stand-alone technology, you choose what goes inside.

That will be transformational. Maybe then they will have to deal with fending off bids for the Company, something you were discussing here the other day.

Best they do some internal prep leading up to that announcement, so that they have the best opportunity to resist such a bid, should it be coming and in the event that it is low.

[supersonico] 24/4/2018 13:33

The Netherlands agree to curtail neonicotinoids
News item 24-04-2018 | 13:30

The Netherlands will agree on Friday with the proposal of the European Commission to restrict the use of plant protection products containing active substances from the group of neonicotinoids. Minister Schouten (LNV) today announced this in a letter to the House of Representatives. The main reason is that these substances are directly harmful to wild bees, honeybees and bumblebees, which are indispensable for the pollination of crops. These resources are therefore a danger to biodiversity.

Minister Schouten follows the scientific advice of the European Food Safety Authorithy (EFSA) and of the Dutch Board for the authorization of plant protection products and biocides (Ctgb). The Member States will take a decision on the basis of EFSA's opinion. On 27 April, the European member states will vote in Brussels.
This concerns a curtailment on three substances, namely imidacloprid, clothianidin and thiamethoxam. Crop protection products containing these substances can then only be used within greenhouses. For seed treatment applications also applies that the treated seed may only be planted in the greenhouse. The proposed restrictions may have consequences for a number of crops in the Netherlands.
Minister Schouten is aware of the possible impact for agricultural entrepreneurs. That is why she will enter into a dialogue with the sector to discuss alternatives.

[supersonico] 24/4/2018 07:46

Organic viticulture is gaining ground worldwide



Currently, 7% to 8% of world wine production is organic. And the Swiss winemakers are still more likely to get involved, even if they still represent only about 5% of the profession.
There are still few vintners producing organic wine in Switzerland. But the trend is there: there has been for a few years a national competition and an international exhibition of organic wines, which was launched last autumn in Montreux.
Organic vineyard surfaces are regularly developed. In 2017, they represented 560 hectares, including reconversion farms, out of a total of nearly 15,000 hectares of vines at the national level.

For example, of 81 farms growing organic vines in 2000, the figure rose to 189 in 2012 and to 230 in 2017.
In 2018, more reconversion areas are expected, particularly in the cantons of Neuchâtel, Vaud and Valais, according to the Swiss Organic Farmers' Federation (Bio Suisse). In Graubünden, a target of 60% of organic vineyards has been set for 2020.
Phenomenon in southern Europe
Currently, 7% to 8% of world wine production is organic, and there are even several grands crus. Development is rather slow in Switzerland, but the phenomenon is more marked in the rest of Europe.
The climate is also in question: it is easier to go organic when it is hot and dry, which explains why in 2015, 88% of the organic vineyards of the European Union were located in Spain, Italy and France.

"There is a climatic impasse, certainly, which is more demanding in oceanic climate, where you sometimes have storms, showers, wetting, but everything is possible, it is a question of will" and management of the technique, says Dominique Levite, consultant and researcher in organic viticulture at the Research Institute for Organic Agriculture in Frick, Canton Aargau.
An image business?
Is the organic trend valid for the whole world? For Alexandre Trüffer, deputy editor of Vinum magazine, making organic wine is a question of image. "I think that 10% of the wines are organic, but 90% of the wine articles and programs are devoted to organic food in a certain way, and there is a great demand for organic products, particularly in the north of France. 'Europe is evolving with consumers,' he explains.
He points out that large producing companies in Chile or Argentina - countries that consume relatively little of their own production - are also looking to organic to meet this demand.
Radio topic: Sandra Zimmerli.
..........................


.................................



Here are the “Transparency” Policy Documents the EPA Does Not Want You to See

[supersonico] 23/4/2018 14:40

Spain, Italy: Tracking the EU Powers in Crop Protection

[supersonico] 23/4/2018 12:05

One in eight bird species is threatened with extinction, global study finds

[supersonico] 22/4/2018 19:59

I'm suggesting the LTIP is a way of both SS/AA being awarded shares in a closed period where a dense news/deal flow is expected as your list suggests. It has the added bonus of leveraging up that award should a take over occur.

If you added to your list the pipeline potential plus the evolving Sustaine opportunities in field crops and conventional pesticide formulation enhancements , sipcam developments, Mevalone approvals in new regions etc I'm not surprised they have not bought as I can imagine the Closed period lasting at least 3 years on what we currently know about.

'The Remuneration Committee has approved the award of options over 4,016,680 ordinary shares of 1 pence each in the Company ("Ordinary Shares") under the LTIP. The awards are in respect of management performance in the financial years ending 31 December 2016 and 31 December 2015, the latter being a "catch up" award following the later than planned implementation of the LTIP'

I could of course have misunderstood the LTIP completely.

[investingisatrickygame] 22/4/2018 18:32

I can't see how they grab shares in a closed period. Obviously, their annual performance bonus up to 100% of basic. Remuneration committees and execs in small employee base AIM companies are always interwoven, unfortunately.

I think they should be buying shares in the open market like the rest of us. No evidence yet, so maybe still in a closed period and close to an RNS. Then we might see some buying.

[supersonico] 22/4/2018 17:55

Investing,

Your list prompted me to look at the LTIP and ask myself if this is a means of SS and AA grabbing some shares during a prolonged closed period and also giving them a nice 1% payday should the company get bought out.


Adoption of New LTIP and Grant of Awards

[investingisatrickygame] 22/4/2018 15:53

Super,

"The Tortoise and the Hare.

I often wonder why Eden has not been swallowed up.. maybe were in a perfect storm where the big boys are just too busy chasing monopolistic hegemony."

I used to wonder about that, but although they had innovation, they hadn't proved it commercially.

1) Proved it in commercial sales
2) Proved it in the commercial field, adopted by farmers and re-ordered for the following year (will happen in 2018)
3) Had the commercial acceptance of a strategic, world reaching partner (Sipcam) that will undoubtedly be acknowledged by other industry players

The following is all personal opinion, is repetitive, but to me it is very valid to Eden absolutely being a potential takeover target now

A)The Chairman said in his prelim report we are at an inflexion point. I take that to mean that commercially we are about to 'lift off' AND that in turn will have the industry pay closer attention to Eden
B)The Sipcam 'very far advanced' situation in regards to Sustaine will effectively launch Sustaine into the R and D and commercial teams of Agro-Chemical players. How long for them to develop their own, can they protect existing patents under threat now, should they buy Eden for that technology or do a commercial deal for that technology
C)Should Bayer come on board now, commercially for those 4 animal health care products, let alone Bayer Crop sciences having 9 products coming off patent with a value of circa $1.6 billion

Eden could, as a result of B) form a company with Sipcam and put Sustaine in it and licence the same to both Sipcam and Eden in perpetuity. This would have the benefit of separating the tech and allowing it to stand-alone and perform alone.

Eden quotes, to my mind, irrelevant numbers in their presentations in regards to market sizes slide 8. Eden will never penetrate that market with product, however, it could change the industries delivery of product with its tech and thus penetrate the market in a very substantial way. Think of Ford Motor Company with windscreen wipers and now every car has them.

So Eden could have a decision to make; to be a product company or a tech company. Eden could be a tech company and Sipcam could be the downstream deliverer of Eden/Sipcam product, globally, for any market.

Back to the point of why Eden has not been taken over or an offer made. I believe the announcement due from Eden re the development with Sipcam and the tech could be the catalyst to that and that the subsequent deal with Bayer will only further enhance Eden's credentials. There is massive potential value in Eden going forward which I doubt they will realise. So a three-year forward evaluation of revenue and P and L from

1) Mevalone
2) Cedroz
3) Bayer
4) Sipcam arrangement
5) Co-encapsulation and stand-alone encapsulation

will exploit Eden and make them a target to potentially bid for. With a current share price of 11.5 pence, an offer of say 50 pence will look very attractive to most investors. I imagine Eden would then want to tell us why that is unacceptable, but I doubt they have the share register support to absolutely reject such a bid, should it come along.

It would be helpful in light of where Eden now is, commercially, if Shore Capital or another would do a full evaluation of the above to ascertain a fair price/value for Eden to be trading at. This would stir up the market, Eden could talk about and endorse the same to their various markets and the share price would likely rise. At this stage, they would then have more supporters on their side, should a cheap bid come along which they wish to defend.

We will see super, but I think both you and I and no doubt others, feel that a bid is definitely a potential outcome and with the pipeline announcements above (+ Terpene Tech), then that could even come this calendar year.